Definitive Healthcare Corp. (DH) Income Statement
DH 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsDH revenue and net income
Where DH's revenue goes
2025Each bar shows an amount and its share of revenue. DH kept −57.5% of revenue as net income.
DH profit margins
DH growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −4.2% | +2.7% | +15.3% | — |
| Gross profit | −7.2% | +0.6% | +15.8% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | −42.9% | −5.9% | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DH quarterly EPS vs estimates
Definitive Healthcare beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.01).
DH income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | $166.2M | $118.3M | $85.5M |
| Cost of revenue | $58.2M | $54.7M | $47.5M | $42.6M | $40.7M | $30.5M | $43.0M |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | $125.5M | $87.8M | $42.5M |
| Research & development | $34.8M | $36.5M | $42.4M | $34.9M | $18.6M | $11.1M | $7.4M |
| Sales, general & admin | $133.3M | $133.1M | $153.4M | $141.1M | $89.3M | $48.7M | $37.2M |
| Total operating expenses | $203.9M | $908.3M | $533.7M | $224.1M | $152.8M | $103.7M | $44.6M |
| Operating income | −$20.6M | −$710.8M | −$329.8M | −$44.0M | −$27.3M | −$15.9M | −$2.2M |
| Interest income | $7.0M | $14.6M | $13.6M | $2.8M | $29,000 | — | — |
| Interest expense | $11.3M | $14.8M | $15.2M | $11.2M | $25.9M | $36.5M | $18.4M |
| Income before taxes | −$209.3M | −$633.7M | −$308.2M | −$41.9M | −$62.8M | −$52.6M | −$36.4M |
| Income taxes | −$10.0M | −$42.3M | −$18.6M | −$17.7M | −$443,000 | $36.5M | $1 |
| Net income | −$138.9M | −$413.1M | −$202.4M | −$7.2M | −$51.9M | −$52.6M | −$36.4M |
| EBITDA | −$141.9M | −$567.2M | −$241.2M | $26.2M | $23.1M | $43.5M | $15.5M |
| EPS (diluted) | $0.20 | $0.35 | $0.30 | $0.24 | −$0.01 | −$0.10 | — |
| Gross margin | 75.9% | 78.3% | 81.1% | 80.9% | 75.5% | 74.2% | 49.7% |
| Operating margin | −8.5% | −281.8% | −131.2% | −19.8% | −16.4% | −13.4% | −2.5% |
| Net margin | −57.5% | −163.8% | −80.5% | −3.2% | −31.2% | −44.5% | −42.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55.2M | $55.9M | $61.5M | $60.0M | $60.8M | $59.2M | $62.3M | $62.7M | $63.7M | $63.5M | $65.9M | $65.3M |
| Cost of revenue | $14.7M | $22.6M | $19.6M | $9.1M | $14.1M | $15.4M | $14.7M | $13.7M | $13.3M | $13.1M | $12.5M | $11.9M |
| Gross profit | $40.5M | $33.3M | $41.9M | $51.0M | $46.6M | $43.8M | $47.6M | $49.0M | $50.5M | $50.4M | $53.4M | $53.4M |
| Research & development | $6.8M | $6.5M | $10.0M | $7.6M | $8.0M | $9.3M | $9.0M | $7.3M | $10.1M | $10.1M | $11.6M | $10.8M |
| Sales, general & admin | $30.0M | $31.7M | $14.3M | $32.7M | $33.1M | $32.9M | $28.9M | $31.5M | $34.1M | $38.6M | $40.2M | $37.3M |
| Total operating expenses | $47.3M | $38.2M | −$135.1M | $59.7M | $50.8M | $228.5M | $147.2M | $274.4M | $420.1M | $66.6M | $63.5M | $348.8M |
| Operating income | −$6.7M | −$4.8M | $177.1M | −$8.7M | −$4.2M | −$184.8M | −$99.6M | −$225.4M | −$369.6M | −$16.2M | −$10.1M | −$295.4M |
| Interest income | $1.3M | $1.3M | $1.5M | $1.7M | $1.7M | $2.1M | $3.2M | $3.7M | $3.7M | $3.9M | $3.8M | $3.5M |
| Interest expense | $2.6M | $2.6M | $2.9M | $3.0M | $3.0M | $2.4M | $3.5M | $3.7M | $3.8M | $3.8M | $3.9M | $3.9M |
| Income before taxes | −$7.8M | −$195.8M | −$17.2M | −$17.3M | −$8.8M | −$166.0M | −$90.6M | −$201.5M | −$328.1M | −$13.5M | −$12.2M | −$266.2M |
| Income taxes | −$345,000 | −$3.4M | −$53,000 | $524,000 | $456,000 | −$10.9M | −$5.9M | −$13.7M | −$21.9M | −$780,000 | $1.2M | −$17.5M |
| Net income | −$5.4M | −$138.6M | −$9.3M | −$14.8M | −$7.6M | −$107.2M | −$59.1M | −$130.9M | −$213.6M | −$9.5M | −$10.2M | −$171.5M |
| EBITDA | $8.6M | −$179.9M | −$439,000 | −$209,000 | $8.5M | −$149.7M | −$74.0M | −$184.7M | −$311.5M | $3.0M | $4.7M | −$249.3M |
| EPS (diluted) | $0.01 | $0.06 | $0.06 | $0.07 | $0.02 | $0.05 | $0.08 | $0.10 | $0.09 | $0.08 | $0.07 | $0.09 |
| Gross margin | 73.5% | 59.6% | 68.1% | 84.9% | 76.7% | 73.9% | 76.4% | 78.2% | 79.2% | 79.4% | 81.0% | 81.8% |
| Operating margin | −12.2% | −8.6% | 287.7% | −14.5% | −6.9% | −312.2% | −159.8% | −359.5% | −579.9% | −25.6% | −15.3% | −452.2% |
| Net margin | −9.8% | −247.9% | −15.1% | −24.7% | −12.4% | −181.2% | −94.8% | −208.8% | −335.2% | −15.0% | −15.5% | −262.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DH's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DH financial results
In fiscal year 2025 (ended December 31, 2025), Definitive Healthcare reported revenue of $241.5 million, down 4.2% from the year before. It had a net loss of $138.9 million, a net profit margin of −57.5%. Diluted earnings per share came to $0.20. Over five years revenue grew at an average rate of 15.3% a year.
See the DH stock overview for the latest quote and news, or the DH chart for price history and technical indicators.
DH income statement FAQ
What is Definitive Healthcare's annual revenue?
Definitive Healthcare reported total revenue of $241.5 million for fiscal year 2025, which ended on December 31, 2025. That was down 4.2% from $252.2 million the previous year.
Is Definitive Healthcare profitable?
No. Definitive Healthcare reported a net loss of $138.9 million in fiscal 2025, a net profit margin of −57.5%; its operating margin was −8.5%.
What is Definitive Healthcare's gross margin?
Definitive Healthcare's gross margin was 75.9% in fiscal 2025: for every $100 of revenue, Definitive Healthcare kept $76 after the direct cost of its products and services.
How much does Definitive Healthcare spend on research and development?
Definitive Healthcare spent $34.8 million on research and development in fiscal 2025, 14.4% of revenue.
How fast is Definitive Healthcare growing?
Revenue grew 15.3% a year on average over the last five fiscal years, from $118.3 million to $241.5 million.
What are Definitive Healthcare's earnings per share?
Definitive Healthcare earned $0.20 per diluted share in fiscal 2025, compared with $0.35 a year earlier.
When will Definitive Healthcare report its next earnings?
Definitive Healthcare is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Definitive Healthcare's fiscal year end?
Definitive Healthcare's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.